Interestingly, another recent analysis by Drapkin et al., reported an association between increased expression of a MYC gene signature and chemotherapy resistance in SCLC PDXs derived from biopsy samples and circulating tumor cells, but failed to observe a correlation between SLFN11 expression and chemotherapy sensitivity41. This evidence concerns the gene SLFN11 and neoplasm.